LDL apheresis is an extracorporal modality to lower the concentration of atherogenic lipoproteins, e.g., LDL cholesterol. We compared two recently introduced whole-blood LDL apheresis systems inpatients with hypercholesterolemia in a randomized cross-over trial with respect to their effects on lipop
β¦ LIBER β¦
Efficacy and Safety of a New Whole-blood Low-density Lipoprotein Apheresis System (Liposorber D) in Severe Hypercholesterolemia
β Scribed by Carsten Otto; Peter Kern; Rolf Bambauer; Stefan Kallert; Peter Schwandt; Klaus G. Parhofer
- Book ID
- 109092640
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 66 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0160-564X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Effects of two whole blood systems (DALI
β
Carsten Otto; Jutta Berster; BΓ€rbel Otto; Klaus G. Parhofer
π
Article
π
2007
π
John Wiley and Sons
π
English
β 98 KB
π 1 views
Direct adsorption of low-density lipopro
β
T. Bosch; A. Lennertz; D. Schenzle; J. DrΓ€ger
π
Article
π
2002
π
John Wiley and Sons
π
English
β 199 KB
## Abstract Direct adsorption of lipoproteins (DALI) is the first lowβdensity lipoprotein (LDL)βapheresis technique by which atherogenic LDL and lipoprotein(a) (Lp(a)) can be selectively removed from whole blood without plasma separation. The present study was performed to evaluate the efficacy, se
The Efficacy and Safety of the New Hepar
β
Frithjof Blessing; Ying Wang; Dorothea Nagel; Dietrich Seidel
π
Article
π
2004
π
John Wiley and Sons
π
English
β 71 KB